New Zealand’s Ministry of Health has approved the world’s first randomized, controlled trial on microdosing LSD. Specifically, the study will be gathering data to understand better if and how microdosing has positive effects on a person’s mood, awareness, and creativity. The study is lead by Dr. Suresh Muthukumaraswamy, an associate profession at the University of Auckland’s School of Pharmacy.
The study will use 40 men, some who will receive a placebo and others LSD. Dr. Muthukumaraswamy makes it clear that they are not ignoring women in their research. They are taking into account the fact that female hormones affect some of the variables they will be measuring. If this study goes well, another will be planned using only women.